HNN3.0
Register
Register
Register

Project cooperationUpdated on 10 December 2025

Designing clinical Trials and epidemiologhical studies

Professor epidemiology and Global Health at National Institute for Medical Research, Muhimbili Centre

Dar es Salaam, Tanzania, United Republic Of

About

Professor Sayoki G. Mfinanga is an established expert in the design and implementation of clinical trials and epidemiological studies, with over two decades of experience leading high-impact research in TB, HIV, NCDs, and vaccine development. He has designed, coordinated, and supervised numerous Phase II–III randomized controlled trials, multi-country implementation studies, and large-scale epidemiological surveys across Africa—including trials such as REMSTART, ACTA, META, INTE-AFRICA, DREAMM, and OPTIC-TB.

His expertise spans trial methodology, protocol development, patient safety oversight, data management systems, biostatistics, operational research, and mixed-methods epidemiology. He has contributed to national and WHO guidelines through evidence generated from these studies, demonstrating his ability to translate trial results into policy. Prof. Mfinanga also teaches “Designing and Conducting Clinical Trials,” supervises PhD and MSc students in epidemiology, and builds research capacity across Africa.

Topic

  • DESTINATION 2: HORIZON-HLTH-2026-01-ENVHLTH-01: Towards a better understanding and anticipation of the impacts of climate change on health
  • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-04: Development of novel vaccines for viral pathogens with epidemic potential
  • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-09: Multisectoral approach to tackle chronic non-communicable diseases: implementation research maximising collaboration and coordination with sectors and in settings beyond the healthcare system (GACD)
  • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
  • DESTINATION 4: HORIZON-HLTH-2026-01-CARE-03: Identifying and addressing low-value care in health and care systems

Type

  • Partner seeks Consortium/Coordinator

Organisation

National Institute for Medical Research, Muhimbili Centre

R&D Institution

Dar es Salaam, Tanzania, United Republic Of

Similar opportunities

  • Project cooperation

    Hospital-based Translational Research & Clinical Trials Partner

    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
    • DESTINATION 4: HORIZON-HLTH-2026-01-CARE-03: Identifying and addressing low-value care in health and care systems
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-11: Understanding of sex and/or gender-specific mechanisms of cardiovascular diseases: determinants, risk factors and pathways
    • DESTINATION 4: HORIZON-HLTH-2026-01-CARE-01: Public procurement of innovative solutions for improving citizens' access to healthcare through integrated or personalised approaches
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-09: Multisectoral approach to tackle chronic non-communicable diseases: implementation research maximising collaboration and coordination with sectors and in settings beyond the healthcare system (GACD)

    Iacopo Megna

    Clinical Project Manager - Grant Officer at University Hospital SS Antonio e Biagio e C. Arrigo

    Alessandria, Italy

  • Project cooperation

    Mapping of Clinical Research Sites in Africa (MAP AFRICA)

    • DESTINATION 1: HORIZON-HLTH-2026-01-STAYHLTH-03: Building public trust and outreach in the life sciences
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-04: Development of novel vaccines for viral pathogens with epidemic potential
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
    • DESTINATION 1: HORIZON-HLTH-2026-01-STAYHLTH-02: Behavioural interventions as primary prevention for Non-Communicable Diseases (NCDs) among young people

    Gloria Rembe Hadebe

    Founder and Managing Director at BioPartners Africa

    Pretoria, South Africa

  • Project cooperation

    Fisabio - Genomics and Health Research Area

    • Partner seeks Consortium/Coordinator
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-04: Development of novel vaccines for viral pathogens with epidemic potential
    • DESTINATION 2: HORIZON-HLTH-2026-01-ENVHLTH-01: Towards a better understanding and anticipation of the impacts of climate change on health
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions

    Belén Mañogil Sáez

    FISABIO International Projects Unit at FISABIO - Foundation for the Promotion of Health and Biomedical Research of the Valencian Community

    Valencia, Spain